Raiffeisen Bank International’s Bristol-Myers Squibb BMY Stock Holding History

Raiffeisen Bank International’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59M	Hold	27,625	–	–	0.02%	348
2026 Q1	$1.68M	Hold	27,625	–	–	0.02%	323
2025 Q4	$1.26M	Hold	27,625	–	–	0.02%	313
2025 Q3	$1.25M	Buy	+27,625	New	+$1.29M	0.02%	300

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Raiffeisen Bank International's BMY Position: Q2 2026 in Review

Raiffeisen Bank International reduced its Bristol-Myers Squibb (BMY) stake by 3.2% in Q2 2026, selling an estimated $822K and leaving 432,969 shares worth $25.4M. The position accounts for 0.3% of the portfolio, ranked #80.

Raiffeisen Bank International first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.7M in Q1 2026. 1,717 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Raiffeisen Bank International held 432,969 shares of Bristol-Myers Squibb worth $25.4M as of Q2 2026.
Raiffeisen Bank International sold 14,315 Bristol-Myers Squibb shares in Q2 2026, an estimated $822K.
Bristol-Myers Squibb made up 0.3% of Raiffeisen Bank International's portfolio in Q2 2026, its #80 holding.
Raiffeisen Bank International first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Raiffeisen Bank International's Bristol-Myers Squibb position peaked at $26.7M in Q1 2026.
1,717 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.